Synthetic FXR Agonist GW4064 Prevents Diet-Induced Hepatic Steatosis and Insulin Resistance
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Synthetic FXR Agonist GW4064 Prevents Diet-Induced Hepatic Steatosis and Insulin Resistance
Authors
Keywords
farnesoid X receptor, glucose homeostasis, hepatic steatosis, obesity
Journal
PHARMACEUTICAL RESEARCH
Volume 30, Issue 5, Pages 1447-1457
Publisher
Springer Nature
Online
2013-02-01
DOI
10.1007/s11095-013-0986-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Synergistic interaction of dietary cholesterol and dietary fat in inducing experimental steatohepatitis
- (2012) Christopher Savard et al. HEPATOLOGY
- High Hepatic SCD1 Activity Is Associated with Low Liver Fat Content in Healthy Subjects under a Lipogenic Diet
- (2012) Günther Silbernagel et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Loss of FXR Protects against Diet-Induced Obesity and Accelerates Liver Carcinogenesis inob/obMice
- (2012) Yanqiao Zhang et al. MOLECULAR ENDOCRINOLOGY
- Internalization of Modified Lipids by CD36 and SR-A Leads to Hepatic Inflammation and Lysosomal Cholesterol Storage in Kupffer Cells
- (2012) Veerle Bieghs et al. PLoS One
- The HIV Matrix Protein p17 Subverts Nuclear Receptors Expression and Induces a STAT1-Dependent Proinflammatory Phenotype in Monocytes
- (2012) Barbara Renga et al. PLoS One
- Scavenger Receptor CD36 Expression Contributes to Adipose Tissue Inflammation and Cell Death in Diet-Induced Obesity
- (2012) Lei Cai et al. PLoS One
- Activation of Pregnane X Receptor by Pregnenolone 16 α-carbonitrile Prevents High-Fat Diet-Induced Obesity in AKR/J Mice
- (2012) Yongjie Ma et al. PLoS One
- Farnesoid X Receptor Deficiency Improves Glucose Homeostasis in Mouse Models of Obesity
- (2011) J. Prawitt et al. DIABETES
- Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C
- (2011) M. E. Miquilena-Colina et al. GUT
- Dietary cholesterol exacerbates hepatic steatosis and inflammation in obese LDL receptor-deficient mice
- (2011) Savitha Subramanian et al. JOURNAL OF LIPID RESEARCH
- DNA microarrays to define and search for genes associated with obesity
- (2009) Yunjung Kim et al. Biotechnology Journal
- Farnesoid X receptor agonist WAY-362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis
- (2009) Songwen Zhang et al. JOURNAL OF HEPATOLOGY
- FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa/fa) obese rats
- (2009) Sabrina Cipriani et al. JOURNAL OF LIPID RESEARCH
- Antiatherosclerotic effect of farnesoid X receptor
- (2008) Andrea Mencarelli et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis
- (2008) Kristiaan Wouters et al. HEPATOLOGY
- Hepatic Fatty Acid Transporter Cd36 Is a Common Target of LXR, PXR, and PPARγ in Promoting Steatosis
- (2007) Jie Zhou et al. GASTROENTEROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now